Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Clozapine Factors in Schizophrenia by Takefumi Suzuki
1
x
$
30.00
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
1
x
$
30.00
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
1
x
$
30.00
Psychopharmacotherapy in Eating Disorders: A Systematic Analysis
1
x
$
30.00
Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
1
x
$
30.00
Negar Fani - Neuropsychological Functioning in Patients with Posttraumatic Stress Disorder Following Short-Term Paroxetine Treatment
1
x
$
30.00
Assesment of Risk Factors for Tardive Dyskinesia (OPEN ACCESS)
1
x
$
0.00
Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression
1
x
$
30.00
OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
1
x
$
0.00
Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
1
x
$
30.00
VOL 47 No. 3 Table of Contents
1
x
$
0.00
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
1
x
$
30.00
Re: An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature
1
x
$
30.00
View Cart
Checkout
Home
unax-lertxundi
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Page load link
Go to Top
